| human | Q5 |
| P4359 | gravsted.dk ID | liseheding |
| P27 | country of citizenship | Kingdom of Denmark | Q756617 |
| P734 | family name | Heding | Q119518573 |
| Heding | Q119518573 | ||
| Heding | Q119518573 | ||
| P735 | given name | Gunhild | Q2634697 |
| Gunhild | Q2634697 | ||
| Lise | Q6981730 | ||
| Lise | Q6981730 | ||
| P1559 | name in native language | Lise Gunhild Pagh Heding | |
| P106 | occupation | researcher | Q1650915 |
| chemical engineer | Q7888586 | ||
| P6978 | Scandinavian middle family name | Pagh | Q42095580 |
| P21 | sex or gender | female | Q6581072 |
| Q70376266 | A double-blind study of the efficacy of neutral human and porcine insulin in type I diabetes using a glucose-controlled insulin infusion system |
| Q51649659 | Abnormal proinsulin/C-peptide ratio in juvenile diabetes. |
| Q46760420 | Action profiles of fast onset insulin analogues |
| Q51640101 | Aorta and muscle metabolism in pigs with peripheral hyperinsulinaemia. |
| Q67256255 | B-cell function in newborn infants of diabetic mothers |
| Q57449739 | B-cell secretion in non-diabetics and insulin-dependent diabetics |
| Q72154825 | C-peptide and proinsulin after oral glucose |
| Q51669216 | C-peptide in children with juvenile diabetes. A preliminary report. |
| Q68871119 | Characterization of monoclonal antibodies against bovine insulin |
| Q70464260 | Clinical Aspects of Insulin–Antigenicity |
| Q42446080 | Comparative study of subcutaneous, intramuscular, and intravenous administration of human insulin |
| Q69455709 | Determination of pancreatic and gut Glucagon-Like Immunoreactivity (GLI) in normal and diabetic subjects |
| Q48025287 | Determination of total serum insulin (IRI) in insulin-treated diabetic patients |
| Q40585216 | Development of Ketonemia in Fasting Patients with Hyperthyroidism |
| Q72927944 | Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism |
| Q39750367 | Differential Changes in the 5-Hydroxytryptamine and Insulin Content of Guinea-Pig B-cells |
| Q40863784 | Effect of insulin induced hypoglycaemia on the blood levels of catecholamines, glucagon, growth hormone, cortisol, C-peptide and proinsulin before and during medication with the cardioselective beta-receptor blocking agent metoprolol in man |
| Q66941190 | Effect of phenformin on plasma levels of insulin, growth hormone, and pancreatic as well as intestinal glucagon in diabetics |
| Q39101282 | Effect of sugars, hydrogen ion concentration and ammonium nitrate on the formation of citric acid by Aspergillus niger |
| Q72394137 | Evaluation of the effect of insulin pump therapy on insulin secretion from transplanted human fetal islets in insulin-dependent diabetics |
| Q72906136 | Glucagon: Structure-Function Relationships Investigated by Sequence Deletions |
| Q45986118 | HLA-types, C-peptide and insulin antibodies in juvenile diabetes. |
| Q59487612 | HLA-types, C-peptide and insulin antibodies in juvenile diabetics [proceedings] |
| Q41002785 | Hormonal Profile, Blood Sugar Control and HLA Patterns in Long-term Insulin Dependent Diabetes with and without Vascular Disease |
| Q51673334 | Human C-peptide in normal and diabetic subjects |
| Q70406345 | Human and porcine insulins are equally effective in the regulation of glucose kinetics of diabetic patients during exercise |
| Q70273209 | Human insulin. Facts and perspectives |
| Q34779326 | Human insulin: study of safety and efficacy in man. |
| Q70672775 | Human proinsulin standards |
| Q70023576 | Human, porcine and bovine ultralente insulin: subcutaneous administration in normal man |
| Q70072339 | Hyperproinsulinaemia in cirrhosis |
| Q51654338 | Hypersecretion of proinsulin in thyrotoxicosis. |
| Q58449586 | INCREASED GUT GLUCAGON RELEASE AS PATHOGENETIC FACTOR IN REACTIVE HYPOGLYCqMIA? |
| Q57449694 | Immunogenicity of monocomponent human and porcine insulin in newly diagnosed Type 1 (insulin-dependent) diabetic children |
| Q70585860 | Impaired metabolic response to regular insulin in the presence of a high level of circulating insulin-binding immunoglobulin G |
| Q71463240 | Increased Release of Gut Glucagon in Reactive Hypoglycaemia |
| Q47930876 | Increased serum immunoreactive insulin in rabbits fed a protein- and mineral-rich diet |
| Q51612053 | Influence of portal delivery of insulin on intracellular glucose and lipid metabolism. |
| Q68893123 | Inhibition by proinsulin of endogenous C-peptide release in healthy man |
| Q70295238 | Insulin, C-peptide and proinsulin in the peripheral blood of patients with liver cirrhosis |
| Q67291746 | Insulin, C-peptide, and Proinsulin in Nondiabetics and Insulin-treated Diabetics: Characterization of the Proinsulin in Insulin-treated Diabetics |
| Q58170154 | Metabolic responses to hypoglycemia in juvenile diabetics |
| Q41544011 | Metabolic studies in acute asthma before and after treatment |
| Q51646532 | Pancreatic A and B cell hyperfunction in the Mendenhall syndrome. |
| Q70571695 | Pancreatic-glucagon-like immunoreactivity after intravenous insulin in normals and chronic-pancreatitis patients |
| Q72602096 | Pharmacokinetics of Subcutaneously Administered Human, Porcine and Bovine Neutral Soluble Insulin to Normal Man |
| Q51658622 | Plasma C-peptide and serum insulin antibodies in diabetic patients receiving pancreatic transplants. |
| Q72900609 | Plasma cyclic nucleotides and plasma catecholamines before and after prolonged treatment with clonidine in hypertensive patients |
| Q67673964 | Plasma insulin, C-peptide, and glucagon levels in acute phase of ethanol-induced hypoglycaemia |
| Q70366206 | Plasma proinsulin and C-peptide concentrations in children with hyperinsulinaemic hypoglycaemia |
| Q40117694 | Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas |
| Q34989946 | Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children. |
| Q71738110 | Preparation of Bovine125I-Tyrosyl-C-Peptide |
| Q122909270 | Radioimmunoassays for Insulin, C-Peptide and Proinsulin |
| Q51672193 | Radioimmunological determination of human C-peptide in serum |
| Q71146358 | Radioimmunological determination of pancreatic and gut glucagon in plasma |
| Q44976254 | Reduction and reoxidation of bovine proinsulin. Effect of pH, zinc ions, temperature and concentration. |
| Q51647855 | Residual B cell function in diabetic children as determined by urinary C-peptide |
| Q67866008 | Separation of the two double-chain bovine intermediates of the proinsulin-insulin conversion I. Chemical, immunochemical, circular dichroism, and biological characterization |
| Q66956890 | Serum IRI in insulin-treated diabetics during a 24-hour period |
| Q93710107 | Serum insulin and antibody levels in patients on insulin |
| Q51645122 | Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis |
| Q44118395 | Specific and direct radioimmunoassay for human proinsulin in serum |
| Q67494709 | Structure-function relationship: immunologic |
| Q67321460 | Studies on Polypeptides, V. Improved Synthesis of Human Proinsulin C-Peptide and its Benzyloxycarbonyl derivative. Circular Dichroism and Immunological Studies of Human C-Peptide |
| Q44968204 | Studies on Polypeptides, VII. Synthesis, Circular Dichroism and Immunological Studien of Tyrosyl C-Peptide of Human Proinsulin |
| Q54062014 | Study of porcine and human isophane (NPH) insulins in normal subjects. |
| Q51642900 | Target fasting glycaemia for pump-treated type-i diabetics |
| Q72552856 | The clinical pharmacology of human insulin (Novo) in normal subjects |
| Q39942788 | The effect of phenformin upon the plasma pancreatic and gut glucagon-like immunoreactivity in diabetics |
| Q51636092 | The effects of hyperinsulinemia on arterial wall and peripheral muscle metabolism in dogs. |
| Q57449754 | The immunogenicity of insulin preparation. Antibody levels before and after transfer to highly purified porcine insulin |
| Q67312464 | The influence of short term submaximal work on the plasma concentrations of catecholamines, pancreatic glucagon and growth hormone in man |
| Q51589922 | The serum concentration of insulin, C-peptide, and proinsulin in patients with acute pancreatitis. |
| Q70517744 | [Behavior of insulin, C-peptide and proinsulin levels in serum in the course of acute pancreatitis] |
| Q67249287 | [Blood serum levels of C-peptide and insulin in diabetics and healthy persons after intravenous administration of glucagon and glucose] |
| Q69898826 | [Effect of phenformin on the plasma somatostatin level in healthy persons] |
| Q69001708 | [Proinsulin secretion and proinsulin: C-peptide indicator in the sera of children with newly detected diabetes mellitus type 1] |
| Q48313796 | Lise G. Heding, 1936-2008. | main subject | P921 |
| Lise Heding | wikipedia |
Search more.